“Whenever you have something new, there may be people who run ahead with it. And there will be people who do things based on less evidence rather than more,” says Joshua Berman. MD.
David Shaffer transformed the study of youth suicide with his detective-like interviews with family members, conducting “psychological autopsies” that led to new prevention methods.
988 suicide call centers are restricting so-called “familiar voices” who call frequently. Dr. Madelyn Gould said that call centers could instead perform regular check-ups with frequent callers.
Robert Klitzman, MD, professor of psychiatry (in sociomedical sciences), discusses what he learned about aging from a late-life friendship with the legendary Lauren Bacall.
Scott Small, MD, a professor of neurology, radiology, and psychiatry, says that changes in memory are normal, but if they disrupt a person’s daily life, people should seek the advice of a clinician.
Dr. David Hellerstein, a professor of clinical psychiatry, spoke about the potential upsides of a new nasal spray that has shown promise in a trial of people with treatment-resistant depression.
Ryan Sultan, MD is concerned about the lack of data on cannabis. "We don’t know what doses are appropriate, what their long-term effects are or even what people are consuming," he says.
A potential vaccine for opioid addiction/overdose prevention has begun Phase 1 clinical trials on humans with research led by Sandra Comer, a professor of neurobiology (in psychiatry) at Columbia.
Smithers Center at Columbia University Irving Medical Center provides evidence-based care to individuals seeking treatment for substance use disorders and co-occurring mental health conditions.
